NCIS Season 22 Cast Whos In For 2025: Complete Renewal Status And Rumors
The long-running CBS procedural NCIS is preparing for a potential twenty-second season as the network has not yet officially canceled the show, though ratings have declined in recent years. Industry observers expect a decision on renewal in the coming months, with showfront continuity hinging on actor contracts and network strategy for mature franchises. This article outlines the current cast status, confirmed departures, and credible rumors for who might return or join the ensemble in 2025 if the series is renewed.
As of early 2025, NCIS remains in a holding pattern. CBS has not issued a renewal or cancellation announcement, a common tactic that allows time for creative restructuring and affiliate negotiations. The uncertainty centers on balancing legacy characters with the need to refresh a lineup that has aged into middle management and elder statesmen of the agency, a demographic shift that naturally alters the show’s dramatic dynamics. Production typically ramps up several weeks before a decision becomes public, so stakeholders are closely watching budget allocations and pilot scripts already circulating in development.
The core team that viewers have followed for seasons is gradually dispersing. Mark Harmon, who portrayed Leroy Jethro Gibbs for nineteen years, officially exited at the end of season twenty-one, closing a significant chapter that helped define the franchise’s tone. David McCallum, who played Dr. Donald “Ducky” Mallard, also left the regular cast after season twenty-one, bringing an end to one of the show’s most enduring portrayals of forensic anthropology and mentorship. Pauley Perrette, known for her role as Abby Sciuto, departed in the previous cycle, reducing the iconic tech lab presence that resonated with fans for more than a decade. These exits collectively represent the departure of foundational pillars, leaving younger performers to shoulder heavier narrative weight in any continuation.
Despite these high-profile exits, some key figures remain tied to the universe through existing agreements. Sean Murray, who portrays Timothy McGee, has publicly signaled his interest in staying involved, aligning with ongoing discussions about digital platforms and streaming spinoffs that extend beyond traditional broadcast seasons. Wilmer Valderrama, as Nicholas Torres, occupies a central role in the field team dynamic, and his contract flexibility will be crucial in determining how the ensemble recalibrates. Brian Dietzen, who has steadily evolved his character Jimmy Palmer from medical assistant to chief medical examiner, is another stabilizing element in the medical wing of the show, providing continuity in forensic subplots. Additionally, Emily Wickersham, who plays Eleanor Bishop, and Rocky Carroll, who embodies Leon Vance, are considered likely to return in 2025 if production resumes, as their characters remain deeply embedded in ongoing story arcs.
Industry trade publications have reported murmurs of discussions regarding potential new faces, with several character actors and mid-level performers being floated as candidates to refresh the ensemble without overhauling the series. These rumored additions are often tied to evolving case loads, international collaborations, or specialized units, such as cyber or counterintelligence divisions, which have become increasingly prominent in modern crime dramas. Sources indicate that the casting focus may lean toward actors who can handle both procedural dialogue and serialized emotional beats, a dual demand that narrows the pool considerably. At the same time, the network is weighing the cost of established names versus emerging talent, a financial calculation that could tilt the balance toward less expensive but compelling performers who can grow into the show’s heightened style.
Should NCIS move forward into a twenty-second season, the structure of storytelling will likely adapt to accommodate a shifting cast matrix. Veteran characters may transition into advisory or mentorship roles, similar to recurring appearances in other long-running franchises, allowing for narrative flexibility while preserving institutional memory. The writers would need to balance screen time carefully, ensuring that new or returning faces do not crowd the central investigations that have anchored the show’s formula. This recalibration could involve rotating guest leads, temporary field team members, and medically focused subplots that highlight Ducky’s legacy in a diminished but still influential capacity. Such adjustments would aim to retain loyal viewers while attracting new demographics who may be unfamiliar with earlier seasons.
Behind the scenes, contract negotiations remain a decisive factor. Talent representatives are reportedly seeking assurances regarding creative input, episode guarantees, and promotional support, all of which influence a performer’s willingness to commit to an uncertain renewal timeline. The interplay between actor availability and network scheduling could create ripple effects, particularly if other series in the NC umbrella, such as NCIS: Los Angeles or NCIS: Hawai‘i, are also renegotiating their own casts. Executives must consider how these decisions affect cross-promotion and shared universe cohesion, as fragmented scheduling might weaken the collective identity that has sustained the franchise across multiple networks and streaming services. Ultimately, the goal is to preserve the essence of NCIS while allowing for evolution, ensuring that the core appeal—team loyalty, case-of-the-week tension, and understated character growth—remains intact for another cycle.
